Blair Jones
SESSIONS
The pandemic has increased the workload of many board members, and liability issues exposed by Caremark, the rising costs of D&O insurance (if you can even get it) have made board service ever more perilous. Is this the end of noses in, fingers out for the board? Does the board need to be more activist with the CEO and senior management going forward?
Should the Compensation Committee morph into a Human Resources Committee? Are compensation metrics meaningful enough to capture stakeholder priorities? Will investors tolerate large pay packages along with layoffs and pay Cuts for employees?
Participants will break into small moderated groups to discuss the issue of board “activism” with senior management. Should it be Fingers In? If so, how far? If not, why not?